Advertisement
Screener

TALPHERA, INC. (TLPH) Fair Value Adjustment of Warrants

1.9 / 5 stars · 28/75 Roast Me

TALPHERA, INC. Fair Value Adjustment of Warrants

TALPHERA, INC. (TLPH) reported Fair Value Adjustment of Warrants of $560.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-12

  • TALPHERA, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was $560.00K.
  • TALPHERA, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$1.22M.
  • TALPHERA, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was $522.00K.
  • TALPHERA, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $1.09M.
  • TALPHERA, INC. fair value adjustment of warrants for fiscal 2025 was $1.31M.
  • TALPHERA, INC. fair value adjustment of warrants for fiscal 2024 was -$717.00K.
  • TALPHERA, INC. fair value adjustment of warrants for fiscal 2023 was -$5.32M.
  • TALPHERA, INC. fair value adjustment of warrants for fiscal 2015 was $2.12M, a 69.66% decline from fiscal 2014.
Period endFair Value Adjustment of Warrants 3 monthFair Value Adjustment of Warrants 6 monthFair Value Adjustment of Warrants 9 monthFair Value Adjustment of Warrants 12 month
2026-06-30$560.00K
10-Q · filed 2026-08-12
-$663.00K
10-Q · filed 2026-08-12
-$141.00K
derived: sum of 3 quarters · filed 2026-08-12
$954.00K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$1.22M
10-Q · filed 2026-05-13
-$701.00K
derived: sum of 2 quarters · filed 2026-05-13
$394.00K
derived: sum of 3 quarters · filed 2026-05-13
$273.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$522.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23
$1.62M
derived: sum of 2 quarters · filed 2026-03-23
$1.50M
derived: sum of 3 quarters · filed 2026-08-12
$1.31M
10-K · filed 2026-03-23
2025-09-30$1.09M
10-Q · filed 2025-11-12
$974.00K
derived: sum of 2 quarters · filed 2026-08-12
$793.00K
10-Q · filed 2025-11-12
-$230.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$121.00K
10-Q · filed 2026-08-12
-$302.00K
10-Q · filed 2026-08-12
-$1.32M
derived: sum of 3 quarters · filed 2026-08-12
-$1.57M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$181.00K
10-Q · filed 2026-05-13
-$1.20M
derived: sum of 2 quarters · filed 2026-05-13
-$1.45M
derived: sum of 3 quarters · filed 2026-05-13
-$1.90M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23
-$1.26M
derived: sum of 2 quarters · filed 2026-03-23
-$1.72M
derived: sum of 3 quarters · filed 2026-03-23
-$717.00K
10-K · filed 2026-03-23
2024-09-30-$241.00K
10-Q · filed 2025-11-12
-$696.00K
derived: sum of 2 quarters · filed 2025-11-12
$306.00K
10-Q · filed 2025-11-12
$704.00K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$455.00K
10-Q · filed 2025-08-14
$547.00K
10-Q · filed 2025-08-14
$945.00K
derived: sum of 3 quarters · filed 2025-08-14
-$761.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.00M
10-Q · filed 2025-05-14
$1.40M
derived: sum of 2 quarters · filed 2025-05-14
-$306.00K
derived: sum of 3 quarters · filed 2025-05-14
$993.00K
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$398.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$1.31M
derived: sum of 2 quarters · filed 2025-03-31
-$9.00K
derived: sum of 3 quarters · filed 2025-03-31
-$5.32M
10-K · filed 2025-03-31
2023-09-30-$1.71M
10-Q · filed 2024-11-13
-$407.00K
derived: sum of 2 quarters · filed 2024-11-13
-$5.72M
10-Q · filed 2024-11-13
2023-06-30$1.30M
10-Q · filed 2024-08-14
-$4.01M
10-Q · filed 2024-08-14
2023-03-31-$5.31M
10-Q · filed 2024-05-14
2016-03-31$331.00K
10-Q · filed 2017-05-08
$50.00K
derived: sum of 2 quarters · filed 2018-03-09
$333.00K
derived: sum of 3 quarters · filed 2018-03-09
$264.00K
derived: sum of 4 quarters · filed 2018-03-09
2015-12-31-$281.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$2.00K
derived: sum of 2 quarters · filed 2018-03-09
-$67.00K
derived: sum of 3 quarters · filed 2018-03-09
$2.12M
10-K · filed 2018-03-09
2015-09-30$283.00K
10-Q · filed 2016-11-02
$214.00K
derived: sum of 2 quarters · filed 2016-11-02
$2.40M
10-Q · filed 2016-11-02
$1.15M
derived: sum of 4 quarters · filed 2017-03-03
2015-06-30-$69.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29
$2.12M
10-Q · filed 2016-07-29
$864.00K
derived: sum of 3 quarters · filed 2017-03-03
$7.28M
derived: sum of 4 quarters · filed 2017-03-03
2015-03-31$2.19M
10-Q · filed 2016-05-02
$933.00K
derived: sum of 2 quarters · filed 2017-03-03
$7.35M
derived: sum of 3 quarters · filed 2017-03-03
$9.86M
derived: sum of 4 quarters · filed 2017-03-03
2014-12-31-$1.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03
$5.17M
derived: sum of 2 quarters · filed 2017-03-03
$7.67M
derived: sum of 3 quarters · filed 2017-03-03
$6.99M
10-K · filed 2017-03-03
2014-09-30$6.42M
10-Q · filed 2015-11-03
$8.93M
derived: sum of 2 quarters · filed 2015-11-03
$8.24M
10-Q · filed 2015-11-03
2014-06-30$2.51M
10-Q · filed 2015-08-04
$1.82M
10-Q · filed 2015-08-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
HYPERION DEFI, INC. (HYPD)United States$0.065B
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99